# Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases With Acute Decompensated Heart Failure With Impaired Renal Function

> **NCT07186062** · — · COMPLETED · sponsor: **Ain Shams University** · enrollment: 60 (actual)

## Conditions studied

- Acute Decompensated Heart Failure (ADHF)
- Cardiorenal Syndrome (CRS)

## Interventions

- **DRUG:** Levosimendan
- **DRUG:** Dobutamine
- **DRUG:** Milrinone

## Key facts

- **NCT ID:** NCT07186062
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-06-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07186062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07186062, "Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases With Acute Decompensated Heart Failure With Impaired Renal Function". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07186062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*